{
    "code": "52027319",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027319",
    "time": "2018-10-12 03:39:52",
    "許可證字號": "衛部藥輸字第027319號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/11\/20",
    "發證日期": "106\/11\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202731901",
    "中文品名": "克顯佳注射劑",
    "英文品名": "Clariscan 0.5 mmol\/ml Solution for Injection",
    "適應症": "核磁共振影像：-神經放射學(neuroradiology)：脊椎及周圍組織的腫瘤、顱內腫瘤。-腹部放射學(abdominal radiology)：原發性及續發性腫瘤。-骨及軟組織之原發性腫瘤。-用於全身其他部位及血管攝影。",
    "劑型": "27D注射液劑",
    "包裝": "15ml in 20ml glass vial、20ml in 20ml glass vial Type I玻璃瓶裝 10ml in 20ml prefilled syringe、15ml in 20ml prefilled syringe、20ml in 20ml prefilled syringe預裝針筒 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "DOTA,GADOLINIUMOXIDE"
    ],
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "0831701100  奇異亞洲醫療設備股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F320003000  GE HEALTHCARE AS",
        "製造廠廠址": "NYCOVEIEN 1, NO-0485, OSLO, NORWAY",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "3690003900",
            "成分名稱": "DOTA",
            "含量描述": "",
            "含量": "202.4600000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "3690004010",
            "成分名稱": "GADOLINIUM OXIDE",
            "含量描述": "",
            "含量": "90.6200000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Clariscan update leaflet-107-08-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027319&Seq=002&Type=9"
        },
        {
            "title": "020273190002-107-01-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027319&Seq=001&Type=8"
        }
    ]
}